Cargando…

HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration

Histone deacetylase (HDAC) 4 is a transcriptional repressor that contains a glutamine-rich domain. We hypothesised that it may be involved in the molecular pathogenesis of Huntington's disease (HD), a protein-folding neurodegenerative disorder caused by an aggregation-prone polyglutamine expans...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mielcarek, Michal, Landles, Christian, Weiss, Andreas, Bradaia, Amyaouch, Seredenina, Tamara, Inuabasi, Linda, Osborne, Georgina F., Wadel, Kristian, Touller, Chrystelle, Butler, Rachel, Robertson, Janette, Franklin, Sophie A., Smith, Donna L., Park, Larry, Marks, Paul A., Wanker, Erich E., Olson, Eric N., Luthi-Carter, Ruth, van der Putten, Herman, Beaumont, Vahri, Bates, Gillian P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841096/ https://www.ncbi.nlm.nih.gov/pubmed/24302884 http://dx.doi.org/10.1371/journal.pbio.1001717

Ejemplares similares

HDAC4 Does Not Act as a Protein Deacetylase in the Postnatal Murine Brain In Vivo
por: Mielcarek, Michal, et al.
Publicado: (2013)

Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease
por: Heikkinen, Taneli, et al.
Publicado: (2012)

Differential Effect of HDAC3 on Cytoplasmic and Nuclear Huntingtin Aggregates
por: Mano, Tatsuo, et al.
Publicado: (2014)

Early detection of exon 1 huntingtin aggregation in zQ175 brains by molecular and histological approaches
por: Smith, Edward J, et al.
Publicado: (2023)

Subcellular Localization And Formation Of Huntingtin Aggregates Correlates With Symptom Onset And Progression In A Huntington’S Disease Model
por: Landles, Christian, et al.
Publicado: (2020)

Development of novel bioassays to detect soluble and aggregated Huntingtin proteins on three technology platforms
por: Landles, Christian, et al.
Publicado: (2021)

Huntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration
por: Kaltenbach, Linda S, et al.
Publicado: (2007)

Phenotype onset in Huntington’s disease knock‐in mice is correlated with the incomplete splicing of the mutant huntingtin gene
por: Franich, Nicholas R., et al.
Publicado: (2019)

Caspase-6 does not contribute to the proteolysis of mutant huntingtin in the HdhQ150 knock-in mouse model of Huntington’s disease
por: Landles, Christian, et al.
Publicado: (2012)

The promise and perils of HDAC inhibitors in neurodegeneration
por: Didonna, Alessandro, et al.
Publicado: (2015)

Blocking the association of HDAC4 with MAP1S accelerates autophagy clearance of mutant Huntingtin
por: Yue, Fei, et al.
Publicado: (2015)

Decreased Striatal RGS2 Expression Is Neuroprotective in Huntington's Disease (HD) and Exemplifies a Compensatory Aspect of HD-Induced Gene Regulation
por: Seredenina, Tamara, et al.
Publicado: (2011)

Oral Administration of the Pimelic Diphenylamide HDAC Inhibitor HDACi 4b Is Unsuitable for Chronic Inhibition of HDAC Activity in the CNS In Vivo
por: Beconi, Maria, et al.
Publicado: (2012)

Dysfunction of the CNS-Heart Axis in Mouse Models of Huntington's Disease
por: Mielcarek, Michal, et al.
Publicado: (2014)

Glial Cell Lineage Expression of Mutant Ataxin-1 and Huntingtin Induces Developmental and Late-Onset Neuronal Pathologies in Drosophila Models
por: Tamura, Takuya, et al.
Publicado: (2009)

Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington’s Disease Pathology
por: Macabuag, Natsuko, et al.
Publicado: (2022)

Mutant huntingtin impairs Ku70-mediated DNA repair
por: Enokido, Yasushi, et al.
Publicado: (2010)

Excessive HDAC activation is critical for neurodegeneration in the rd1 mouse
por: Sancho-Pelluz, J, et al.
Publicado: (2010)

The Sushi Domains of Secreted GABA(B1) Isoforms Selectively Impair GABA(B) Heteroreceptor Function
por: Tiao, Jim Y., et al.
Publicado: (2008)

Mutant Huntingtin Protein Interaction Map Implicates Dysregulation of Multiple Cellular Pathways in Neurodegeneration of Huntington’s Disease
por: Podvin, Sonia, et al.
Publicado: (2022)

Huntingtin and Other Neurodegeneration-Associated Proteins in the Development of Intracellular Pathologies: Potential Target Search for Therapeutic Intervention
por: Churkina (Taran), Aleksandra S., et al.
Publicado: (2022)

Correlative light and electron microscopy suggests that mutant huntingtin dysregulates the endolysosomal pathway in presymptomatic Huntington’s disease
por: Zhou, Ya, et al.
Publicado: (2021)

Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice
por: Agustín-Pavón, Carmen, et al.
Publicado: (2016)

The Huntington's Disease-Related Cardiomyopathy Prevents a Hypertrophic Response in the R6/2 Mouse Model
por: Mielcarek, Michal, et al.
Publicado: (2014)

Detection of Alpha-Rod Protein Repeats Using a Neural Network and Application to Huntingtin
por: Palidwor, Gareth A., et al.
Publicado: (2009)

Huntingtin and the Synapse
por: Barron, Jessica C., et al.
Publicado: (2021)

Meso scale discovery-based assays for the detection of aggregated huntingtin
por: Reindl, Wolfgang, et al.
Publicado: (2019)

TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models
por: Hegde, Ramanath Narayana, et al.
Publicado: (2020)

A Huntingtin Peptide Inhibits PolyQ-Huntingtin Associated Defects
por: Arribat, Yoan, et al.
Publicado: (2013)

The evolution of the huntingtin-associated protein 40 (HAP40) in conjunction with huntingtin
por: Seefelder, Manuel, et al.
Publicado: (2020)

Disruption to schizophrenia-associated gene Fez1 in the hippocampus of HDAC11 knockout mice
por: Bryant, Dale T., et al.
Publicado: (2017)

Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia-telangiectasia
por: Li, Jiali, et al.
Publicado: (2012)

Ku70 Alleviates Neurodegeneration in Drosophila Models of Huntington's Disease
por: Tamura, Takuya, et al.
Publicado: (2011)

Linking Huntingtin to motility
por: Tuma, Rabiya S.
Publicado: (2006)

Huntingtin Lowering Strategies
por: Marxreiter, Franz, et al.
Publicado: (2020)

SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease
por: Mielcarek, Michal, et al.
Publicado: (2011)

A C-terminal ataxin-2 disordered region promotes Huntingtin protein aggregation and neurodegeneration in Drosophila models of Huntington’s disease
por: Huelsmeier, Joern, et al.
Publicado: (2021)

Correction: Ku70 Alleviates Neurodegeneration in Drosophila Models of Huntington's Disease
por: Tamura, Takuya, et al.
Publicado: (2012)

HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements
por: Mielcarek, Michal, et al.
Publicado: (2015)

An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline
por: Trzeciakiewicz, Hanna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vsdrld9iqeh5jfr3icsuusfvmo